Soluble intercellular adhesion molecule 1 is released by human melanoma cells and is associated with tumor growth in...

Area of Science:

• Immunology
• Cell Biology
• Oncology

Background:

• Intercellular Adhesion Molecule 1 (ICAM-1) plays a role in immune responses.
• Elevated soluble ICAM-1 is observed in melanoma patients, but its source is unclear.
• Melanoma cell lines offer a model to study ICAM-1 regulation.

Purpose of the Study:

• To investigate how cytokines regulate ICAM-1 expression on human melanoma cells.
• To determine if melanoma tumors release soluble ICAM-1 in vivo.
• To explore the potential source of elevated soluble ICAM-1 in melanoma patients.

Main Methods:

• Utilized the human melanoma cell line A375M.
• Treated cells with cytokines including Interleukin 1 (IL-1), Interleukin 6 (IL-6), Tumor Necrosis Factor (TNF), and gamma-interferon (IFN-γ).
• Measured cell surface and soluble ICAM-1 levels; analyzed serum from tumor-bearing mice.

Main Results:

• Unstimulated A375M cells expressed cell surface ICAM-1 but minimal soluble ICAM-1.
• IL-1, IL-6, TNF, and IFN-γ increased cell surface ICAM-1 expression.
• TNF, IL-1, and IFN-γ induced the release of soluble ICAM-1.
• Soluble human ICAM-1 was detected in serum from mice bearing human melanoma tumors, correlating positively with tumor weight.

Conclusions:

• Cytokines significantly regulate both cell surface and soluble ICAM-1 expression in melanoma cells.
• Melanoma tumors can be a source of soluble ICAM-1.
• Cytokine-induced release of ICAM-1 from tumors may be relevant to immune recognition in melanoma.